SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Attack II - A Complete Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Paul Shread who wrote (11200)7/9/2001 12:16:16 PM
From: TechTrader42  Read Replies (3) | Respond to of 52237
 
It looks like MSFT might just fill that gap from April, at the 200 SMA. Isn't that something?



To: Paul Shread who wrote (11200)7/9/2001 1:39:17 PM
From: Claud B  Respond to of 52237
 
Paul, drug stocks have their own problems. From a suddenly unfriendly FDA to a leaderless FDA. You can add to that a stretch out to 18 mos. for new drug approvals.

Claud


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News